CRVS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Corvus Pharmaceuticals (CRVS) Earnings Date & Reports

Industry: @Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

CRVS is expected to report earnings to fall 80.67% to -11 cents per share on March 06

Corvus Pharmaceuticals CRVS Stock Earnings Reports

Q4'24

Est.

$-0.12

Q3'24

Missed

by $0.49

Q2'24

Beat

by $0.05

Q1'24

Est.

$-0.12

Q4'23

Missed

by $0.02

The last earnings report on November 12 showed earnings per share of -60 cents, missing the estimate of -10 cents. With 1.37M shares outstanding, the current market capitalization sits at 474.86M.

View a ticker or compare two or three

Compare

CRVS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CRVS
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for CRVS (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a provider of anticancer immuno-oncology drugs

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

863 Mitten Road

Phone

+1 650 900-4520

Employees

Web

https://www.corvuspharma.com